Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Immunsystem I.M.S. AB is a small private Swedish biotechnology company based in Uppsala focused on antibody research and development. The company was founded by researchers associated with Uppsala University and the Swedish University of Agricultural Sciences, and historically worked on the production and use of antibodies in diagnostics. Publicly available descriptions indicate that the company positions its technology as a low-toxicity approach suited for long-term prophylactic use, but detailed current clinical pipeline information is not readily disclosed. The company appears to operate primarily as an early-stage antibody and diagnostics-oriented R&D organization rather than a commercial-stage therapeutics company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on I.M.S..